Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API

Dano Egamberdieva

19 ta ish

1Tashkent Pediatric Medical Institute Tashkent, Republic of Uzbekistan

  1. EFFECTS OF L - CARNITINE ON SYSTEMIC INFLAMMATION AND OXIDATIVE STRESS IN COVID-19 PATIENTS

    Raimkulova Narina1, Daminov Botir1, Dano Egamberdieva +2

    MaqolaHermeneutics and Narrative IdentityZenodo (CERN European Organization for Nuclear Research)20210 iqtibos
    ABI

  2. MO593: Study of Cardiopulmonal Parameters in Patients with CKD During Renal Rehabilitation

    Durdona Saipova, Dano Egamberdieva

    MaqolaHealthcare Systems and Public HealthNephrology Dialysis Transplantation20220 iqtibos
    ABI

  3. #3421 MRI PREDICTORS OF DIASTOLIC DYSFUNCTION OF THE LEFT VENTRICLE

    Dano Egamberdieva, Iroda Ruzmetova, Miao Yu +1

    MaqolaCardiovascular Function and Risk FactorsNephrology Dialysis Transplantation20230 iqtibos
    ABI

  4. #5764 STUDY OF THE INFLUENCE OF PHYSICAL ACTIVITY ON THE FUNCTION OF EXTERNAL RESPIRATION IN PATIENTS WITH CKD IN THE PROCESS OF REHABILITATION

    Durdona Saipova, Iroda Ruzmetova, Dano Egamberdieva

    MaqolaHuman Health and DiseaseNephrology Dialysis Transplantation20230 iqtibos
    ABI

  5. #3423 DIAGNOSTIC SIGNIFICANCE MAGNETIC RESONANCE IMAGING IN CHRONIC HEART FAILURE OF VARIOUS GENESIS

    Dano Egamberdieva, Iroda Ruzmetova, Mengmeng Yu +1

    MaqolaCardiac Imaging and DiagnosticsNephrology Dialysis Transplantation20230 iqtibos
    ABI

  6. #4977 ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH COVID-19 DURING ANTIOXIDANT THERAPY

    Dano Egamberdieva, Iroda Ruzmetova, Narine Raimkulova

    MaqolaCOVID-19 Clinical Research StudiesNephrology Dialysis Transplantation20230 iqtibos
    ABI

  7. #5613 ASSESSMENT OF THE PROGRESSION OF CKD TAKING INTO ACCOUNT METABOLIC CHANGES

    Guzal Karimdjanova, Dano Egamberdieva, Iroda Ruzmetova

    MaqolaCardiac, Anesthesia and Surgical OutcomesNephrology Dialysis Transplantation20230 iqtibos
    ABI

  8. Study of the comorbid background and features of the clinical course of chronic obstructive pulmonary disease (COPD) in combination with atrial fibrillation

    Guzal Karimdjanova, Dano Egamberdieva

    MaqolaChronic Obstructive Pulmonary Disease (COPD) Research20230 iqtibos
    ABI

  9. #1534 Risk of CKD progression taken into account of metabolic changes

    Dano Egamberdieva, Iroda Ruzmetova

    MaqolaDiet and metabolism studiesNephrology Dialysis Transplantation20240 iqtibos
    ABI

  10. #1146 Role of renal dysfunction in the use of anticoagulants in COPD patients with atrial fibrillation

    Guzal Karimdjanova, Dano Egamberdieva, Iroda Ruzmetova

    MaqolaChronic Obstructive Pulmonary Disease (COPD) ResearchNephrology Dialysis Transplantation20240 iqtibos
    ABI

  11. #1533 The relationship between the severity of anemia, the level of inflammation markers and the dose of epoetin in patients in pre-dialysis stages of CKD

    Dano Egamberdieva, Iroda Ruzmetova

    MaqolaErythropoietin and Anemia TreatmentNephrology Dialysis Transplantation20240 iqtibos
    ABI

  12. #1036 Studying the quality of life in patients with CKD during the short physical rehabilitation program

    Durdona Saipova, Dano Egamberdieva, Iroda Ruzmetova

    MaqolaPeripheral Artery Disease ManagementNephrology Dialysis Transplantation20240 iqtibos
    ABI

  13. #1670 Gut-lung-kidney axis: gut microbiota and kidney disfunction in patients with COPD

    Durdona Saipova, Dano Egamberdieva, Iroda Ruzmetova

    MaqolaGut microbiota and healthNephrology Dialysis Transplantation20250 iqtibos
    ABI

  14. INTESTINAL MICROBIOTA AND THE INFLAMMAGING PHENOMENON IN PATIENTS WITH RHEUMATOID ARTHRITIS: THE ROLE OF DYSBIOTIC DISORDERS IN MAINTAINING CHRONIC SYSTEMIC INFLAMMATION

    Dano Egamberdieva, Shahnoza Akhmedova

    MaqolaGut microbiota and healthZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  15. INTESTINAL MICROBIOTA AND THE INFLAMMAGING PHENOMENON IN PATIENTS WITH RHEUMATOID ARTHRITIS: THE ROLE OF DYSBIOTIC DISORDERS IN MAINTAINING CHRONIC SYSTEMIC INFLAMMATION

    Dano Egamberdieva, Shahnoza Akhmedova

    MaqolaGut microbiota and healthZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  16. MICROBIAL ANTIGENS AND HUMORAL IMMUNE RESPONSE IN RHEUMATOID ARTHRITIS: CURRENT STATE OF THE PROBLEM, ACHIEVEMENTS AND UNRESOLVED ISSUES.

    Dano Egamberdieva, Shahnoza Akhmedova

    MaqolaRheumatoid Arthritis Research and TherapiesZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  17. MICROBIAL ANTIGENS AND HUMORAL IMMUNE RESPONSE IN RHEUMATOID ARTHRITIS: CURRENT STATE OF THE PROBLEM, ACHIEVEMENTS AND UNRESOLVED ISSUES.

    Dano Egamberdieva, Shahnoza Akhmedova

    MaqolaRheumatoid Arthritis Research and TherapiesZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  18. THE ROLE OF DYSBIOTIC DISORDERS IN MAINTAINING CHRONIC SYSTEMIC INFLAMMATION IN PATIENTS WITH RHEUMATOID ARTHRITIS

    Dano Egamberdieva, Shahnoza Akhmedova

    MaqolaRheumatoid Arthritis Research and TherapiesZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  19. THE ROLE OF DYSBIOTIC DISORDERS IN MAINTAINING CHRONIC SYSTEMIC INFLAMMATION IN PATIENTS WITH RHEUMATOID ARTHRITIS

    Dano Egamberdieva, Shahnoza Akhmedova

    MaqolaRheumatoid Arthritis Research and TherapiesZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI